Posted on 12/13/2021 2:23:21 AM PST by nickcarraway
China's Brii Biosciences said on Sunday (Dec 12) lab studies showed that its Covid-19 antibody cocktail retained activity against the Omicron variant, although one of the antibodies showed a substantial drop in activity when tested alone.
Test details for the dual-antibody treatment, which last week became the first approved Covid-19 antibody cocktail in China, would not be available until publication in a scientific journal, but results from three independent labs showed similar pattern, Brii chief executive Hong Zhi said on Monday.
Although no purchase order for the treatment has been announced, the firm was able to secure manufacturing capacity of one million doses for 2022 and 2023 each, Hong said in an investor call, adding it already has about 80,000 doses available in its inventory.
(Excerpt) Read more at asiaone.com ...
So why are they still trying to steal these formulas from American and other nation’s corporations? Their inoculations don’t require a slave camp in order to “prevent the spread”?
Does the NIH have a half interest in this concoction as well? Has Nancy Pelosi bought stock in the start up?
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.